)
CCL Industries (CCL-B) investor relations material
CCL Industries Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 sales rose 12.9% to $2,219.9M, comprising 6.9% organic growth, 3.9% acquisition-related growth and 2.1% FX contribution.
Net earnings were $223.6M versus $210.8M; adjusted basic EPS increased 12.4% to $1.36, and basic EPS was $1.32.
Financial highlights
Operating income was $356.3M, up 10.7% reported; growth was 8% excluding FX and 11.3% excluding $2M of Sleever inventory accounting adjustments.
Q3 EBITDA was $461.7M, up 8% excluding FX; net finance expense rose to $20.3M from $18.2M.
Q3 free cash flow from operations was $236.5M versus $333.4M; LTM through September was $860.2M versus $755.8M.
Nine-month sales were $6,269.1M, up 7% excluding FX; operating income rose 5% and net income rose 2% excluding FX.
Nine-month adjusted basic EPS was $3.91 versus $3.61; basic EPS was $3.81 versus $3.60.
Outlook and guidance
Q4 core orders in home and personal care, healthcare, food and beverage, and core labels were expected to remain stable; CCL Design faced further memory-chip supply disruption in its peak season.
Avery and Checkpoint faced strong Q4 comparisons; Avery demand was expected to resemble Q3, while EcoFloat growth and good Americas results were expected to continue.
European pressure-sensitive materials de-stocking was expected to continue into Q4; FX was expected to be a modest positive.
2026 capital spending was expected to underspend the $470M plan; 2027 CapEx was expected to be near $470M.
- FY adjusted EPS reached $3.76 as Q4 results and early-2024 orders improved.CCL-B
Q4 2023 - Q2 2026 saw record sales, EPS growth, and strong cash flow, led by CCL and Innovia.CCL-B
Q2 2026 - Sales up 2.8%, adjusted EPS rose, and cash flow strong despite inflationary headwinds.CCL-B
Q1 2026 - Record sales, earnings, and free cash flow in 2025, with increased shareholder returns.CCL-B
Q4 2025 - Q3 sales and EPS rose, cash flow was strong, and $467.9M was returned to shareholders.CCL-B
Q3 2025 - Q3 2024 delivered strong sales and earnings growth, led by RFID and robust liquidity.CCL-B
Q3 2024 - Q2 2024 saw double-digit sales and profit growth, led by RFID and a major acquisition gain.CCL-B
Q2 2024 - Q1 2025 saw record sales, earnings, and cash flow, with robust shareholder returns.CCL-B
Q1 2025 - Record 2024 sales and earnings, strong cash flow, and positive but cautious 2025 outlook.CCL-B
Q4 2024
)
)
)
)
)
)
)
)